Roflumilast Cream (ARQ-151) 0.15% and 0.3% Improved Burden of Signs and Symptoms in Adults With Chronic Plaque Psoriasis in a Phase 2b Study. (2020). SKIN The Journal of Cutaneous Medicine, 4(6), s70. https://doi.org/10.25251/skin.4.supp.70